Survival status AHR [95% CI]
Variable   Death Alive P-value
CD4 cells/µl ≥200 20 75   1.00    
100-199 132 296 0.14 1.61 0.855 3.019
50-99 96 116 0.033 2.03 1.058 3.889
<50 118 77 0.019 2.18 1.140 4.182
Anemia Non anemic 84 346   1.00    
Mild anemia 116 143 <0.001 2.62 1.886 3.640
Moderate to severe anemia 102 42 <0.001 4.29 2.998 6.131
WHO clinical stage Stage I-III 295 520   1.00    
Stage IV 71 44 0.011 1.63 1.118 2.371
Adherence Good 168 480   1.00    
   Poor 131 60 <0.001 3.11 2.341 4.129
CTX prophylaxis  Yes 194 360   1.00    
No 133 145 <0.001 1.66 1.272 2.172
Table 2: Multivariate Cox’s proportional hazards regression model showing significant independent predictors of mortality of patients started HAART from September, 2005 to August, 2010 at Debre Markos Hospital, 2012.